ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Northwest Biotherapeutics Inc (QB)

Northwest Biotherapeutics Inc (QB) (NWBO)

0.475
0.0149
( 3.24% )
Updated: 12:22:50

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.475
Bid
0.475
Ask
0.4766
Volume
840,595
0.4601 Day's Range 0.487
0.4001 52 Week Range 1.11
Market Cap
Previous Close
0.4601
Open
0.47
Last Trade
15000
@
0.475
Last Trade Time
12:22:50
Financial Volume
$ 398,380
VWAP
0.473926
Average Volume (3m)
1,682,703
Shares Outstanding
1,189,970,308
Dividend Yield
-
PE Ratio
-3.14
Earnings Per Share (EPS)
-0.05
Revenue
1.93M
Net Profit
-64.37M

About Northwest Biotherapeutics Inc (QB)

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Northwest Biotherapeutics Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker NWBO. The last closing price for Northwest Biotherapeutics (QB) was $0.46. Over the last year, Northwest Biotherapeutics (QB) shares have traded in a share price range of $ 0.4001 to $ 1.11.

Northwest Biotherapeutics (QB) currently has 1,189,970,308 shares outstanding. The market capitalization of Northwest Biotherapeutics (QB) is $202.29 million. Northwest Biotherapeutics (QB) has a price to earnings ratio (PE ratio) of -3.14.

NWBO Latest News

Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia

Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia   Miami, FL -- (InvestorsHub NewsWire – November 15, 2023) –...

Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000

Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000  Miami, FL-- (InvestorsHub NewsWire – November 9, 2023) – EmergingGrowth.com, a leading independent small cap...

Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo

Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo   Miami, FL-- (InvestorsHub NewsWire – November 7, 2023) – EmergingGrowth.com, a...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0245-4.90490490490.49950.520.460114680230.47942927CS
4-0.145-23.38709677420.620.620.460115505240.51322291CS
12-0.068-12.52302025780.5430.650.460116827030.54129731CS
26-0.1855-28.08478425440.66050.9290.460117391810.64875197CS
52-0.03-5.940594059410.5051.110.400118537970.65968792CS
156-1.005-67.90540540541.482.150.386220937970.8577946CS
2600.2179.24528301890.2652.540.00523002450.84985499CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
YYGHYY Group Holding Ltd
$ 3.9991
(76.95%)
12.99M
ACONAclarion Inc
$ 0.4915
(70.66%)
87.49M
SGBXSafe and Green Holdings Corporation
$ 0.2259
(56.77%)
108.1M
BRFHBarfresh Food Group Inc
$ 1.47
(42.72%)
38.28M
MNYMoneyHero Ltd
$ 2.49
(38.33%)
4.32M
EJHE Home Household Service Holdings Ltd
$ 0.7707
(-73.52%)
9.71M
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.2701
(-36.49%)
12.85M
ATNIATN International Inc
$ 19.45
(-32.28%)
184.61k
BNAIBrand Engagement Network Inc
$ 2.6699
(-28.42%)
153.09k
CYCCCyclacel Pharmaceuticals Inc
$ 1.665
(-27.61%)
2.95M
SGBXSafe and Green Holdings Corporation
$ 0.2259
(56.77%)
108.1M
SQQQProShares UltraPro Short QQQ
$ 12.2803
(3.98%)
89.19M
ACONAclarion Inc
$ 0.4915
(70.66%)
87.49M
TSLATesla Inc
$ 164.115
(1.22%)
64.6M
PCSAProcessa Pharmaceuticals Inc
$ 2.225
(37.35%)
60.85M

NWBO Discussion

View Posts
manibiotech manibiotech 2 minutes ago
Well then that begs another question , if NWBO is paying for most or almost all of advent build up , was it not done within NWBO so we could have transparency in regards to the cost of the specials program , how much revenue received and by whom . Why did NWBO shareholders pay to build a private company in which they have no stake and can’t see transparently the revenue streams including money collected from specials program ?? Don’t you thing company explaining the rationale in black and white without “smart” people speculating here on the board as expert opinions .
👍️0
ilovetech ilovetech 3 minutes ago
Does a CUSIP code registration need to be forecasted in advance of any filing, or can the company spring it on the market by surprise?
👍️0
fluteman fluteman 3 minutes ago
$NWBO

The "dormant" company Revimmune Ltd, has been confirmed today, that "its intended future activities are lawful" pic.twitter.com/yneVxPhJza— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) April 25, 2024
👍️ 1
Chiugray Chiugray 5 minutes ago
Very good points.
👍️0
learningcurve2020 learningcurve2020 14 minutes ago
Governance, board seats, Independence, shareholder influence, fiduciary duties, proxy battles...All things as alien to you as can be. Just so sad really.
🐀 1 👺 1
GermanCol GermanCol 25 minutes ago
I had to use Google Translate, lol. German is not my primary language.
👍️0
Truthfan Truthfan 25 minutes ago
“Certainly, we don't know what is meant by "franchise", but it could be as simple as licensing out the technology to others who can produce it for their designated markets, including use in combo therapies.”

Yes, of course, many opportunities present themselves with NWBO’s breakthrough technology but with the current silence, we can only speculate. The point I was attempting to highlight in my post was the “administered in community settings” verbiage wherein brick and mortar location is not always available.

Further, an interesting nugget, EW Healthcare Partners held Cognate BioServices in their portfolio overseen by Evis Hursever, Managing Director, prior to CRL buyout. Presently, Ms. Hursever, chairs the Board of Germfree,

Thank you for adding additional information; we only have each other to depend on as we offer our thoughts and due diligence despite all the neighborhood pests on the board.

Best
👍️0
ilovetech ilovetech 33 minutes ago
So my shedding further light on Facebook's decision to interrupt, and censor LL's comments during an interview with Al Musella earned a deletion request by one of our members here. I rest my case!
🎯 1 👍️ 2
georgebailey georgebailey 40 minutes ago
Funny, a couple industry analogies ran thru my mind that was one of them.
👍️0
ilovetech ilovetech 47 minutes ago
Here's my two cents - When LL was interviewed to get her opinion on needed FDA guideline changes, I recall her stating, that she, and colleagues have questioned the helmet data, and further added, no one really quiet understands how it really works?
👍️ 1 💥 1
meirluc meirluc 48 minutes ago
Apologies for butting in but I am guessing that if I were an oncologist
of a patient with unlimited funds, I would not recommend the helmet
because I would not know whether or not the helmet negates the
immunological benefits of the DCVax-L treatment.

OTOH, I would definitely add poly ICLC to the DCvax-L treatment.
In fact, I would treat all patients (affluent and poor) with both DCVax-L
and polyICLC. With respect to adding keytruda to the mix, I do not yet
know whether enough decisive data is available.
👍️ 3 💯 1
newman2021 newman2021 48 minutes ago
Let us look for some key languages in the upcoming 10Q that will shed some light about why if they are buying those GMP components and installing them there at Sawston. I think UK approval comes with FW techline closed EDEN system manufacturing in place where multiple less-expensive cleanrooms house hundreds of FWs capable of making thousands of vaccines each month, imo; billions of revenue in the making guys, imo..
👍️ 2 💥 2
ilovetech ilovetech 53 minutes ago
Continued - To reinforce, and to raise awareness of how pervasive criminal Corporate collusion has become: 350 positive journals on COVID-19 vaccines, published around the time of the rollout, and mandated to the greatest extent Gov't overrich made possible has been quietly wiped off the Internet!! Keep sleeping.
👍️ 1
Investor082 Investor082 54 minutes ago
That appears to be one of the reasons why they brought the new board member, Pat Sarma to the team. One of the successful companies he co-founded licensed BIOS in the early PC era.
🎯 1 👍️ 2 💥 1
Inquirig Inquirig 55 minutes ago
Again, change your screen name... It makes no sense.
You are not an investor, IMO.
You are a day dreaming bag holder who knows nothing about companies or stocks
🐀 1 👺 1 💩 3 🖕 2
Investor082 Investor082 58 minutes ago
“Advent has paying clients that it actually produces products for and makes money off of them.”

Regardless of contracts with other companies, NWBO will be their biggest client by a long shot. So it’s in the best interest of Advent that DCVAX-L succeeds and gets approved quickly in the UK! Thats why they have been building that team to prepare for commercial launch.
👍️ 3 💥 1 😂 1 🤡 1
georgebailey georgebailey 59 minutes ago
Bas2020 I think your description is exactly what franchise means. Licensing the platform and Eden’s from trial to commercialization.
The entire industry has changed dramatically because of new precise forecasting tools, dendretic cell as a platform, length of trials,number of participants in trials, personalized therapies and all made commercially feasible via Eden’s.
Franchises are turnkey operations and that’s what we have.
🏆️ 1 👍️ 3 💥 1
newman2021 newman2021 1 hour ago
That's correct.. no way shaving or scalping the head with that helmet once DcVaxL is approved; patients get a huge relief. Yes, with Keytruda and PCLYC, we are talking about curing the gbm or any solid tumor even it is at stage 4, or the patient was in hospice, imo.
👍️ 1 💥 1 😂 1
norisknorewards norisknorewards 1 hour ago
does this earn you a spot bonus?
👍️ 1 🤣 1
skitahoe skitahoe 1 hour ago
Newman, the question I might have is if DCVax-L is approved and a patient has unlimited funds, would any oncologist recommend using both the vaccine and the helmet, and of course Keytruda and or Poly ICLC.

Gary
👍️ 1
GermanCol GermanCol 1 hour ago
Thanks ilovetech, the same to you!! I will continue holding NWBO shares and would like to continue sharing my analyses and thoughts.
👍️ 4 🙂 1 🙏 1
newman2021 newman2021 1 hour ago
how comes the helmet scam is still alive?
https://finance.yahoo.com/quote/NVCR?.tsrc=fin-srch
🤡 1
newman2021 newman2021 1 hour ago
https://finance.yahoo.com/quote/CVM?.tsrc=fin-srch
what happened to CVM? Has that Multikine ever been applied for regulatory approval??
👍️0
theorysuit theorysuit 2 hours ago
Yeah you should be planning, but NWBO has no intention of marketing this product. Build it and they will come. That is such a laughable statement that only a naive person would make about an autologous products/process. I thought this company learned from DNDN's mistakes....please. So much BS on this board it is incredible.
🐀 2 👍️ 1 👺 1 💥 1 😈 1
flipper44 flipper44 2 hours ago
I’ll be looking to further support as well, albeit, probably in smaller doses. Good luck.
👍️ 4 💥 1
skitahoe skitahoe 2 hours ago
That is simple, LP has set a price point that they would be considered to be insane to meet until the share price is near half that price.

Gary
🎯 1 👍️ 2
dstock07734 dstock07734 2 hours ago
I am a just simple-minded retailer. I am not a journal reviewer and I am not equipped to read fancy statistical analysis. That's why I don't understand the significance of the analysis.
👍️0
norisknorewards norisknorewards 2 hours ago
Personally, I think you're full of sh..

Especially with your disclaimer on English as a scapegoat, you're English is the least of the problems here.
👎️ 1 😬 1 🙄 1
dstock07734 dstock07734 2 hours ago
IC,

I thought you should specifically mentioned about me. How many posts did I address to you specifically? You show no appreciation.

BTW, are these words from you or Adam Fraudstein? Last time I know your talk is fully of vulgarity.
🏆️ 1 👍️ 2 💥 1 🤡 1
bas2020 bas2020 2 hours ago
Certainly, we don't know what is meant by "franchise", but it could be as simple as licensing out the technology to others who can produce it for their designated markets, including use in combo therapies.
👍️ 3 💥 1
GermanCol GermanCol 2 hours ago
Thanks NotSure2. You are right, I am not a swing trader and don't even know how they work, lol. I was expecting some people accusing me of that or similar things for sharing my thoughts.

And thanks for clarifying hoping / wishing vs. expecting. I could have got confused with the exact meaning of those words and lost part of the content in Margin Buu's reply for English not being my primary language.
👍️ 1
learningcurve2020 learningcurve2020 2 hours ago
Of course. Just look at Geron. In the recent presentation the CEO stressed Medical Affairs and the Commercial Organization are in place. Just try to find the same copy in NWBO's filing.

>>Commercial Plans for Imetelstat
If imetelstat is approved in lower-risk MDS for marketing by regulatory authorities, we plan to commercialize imetelstat ourselves in the U.S. Our U.S. launch strategy is designed to prepare imetelstat, the market and the company to ensure broad reimbursement and deliver a seamless customer experience to all stakeholders at launch. Several long-lead time activities have already been completed, such as securing a global trademark for the imetelstat brand name; finalizing third party logistics, our distribution network, and our patient support providers; and onboarding highly experienced commercial and medical affairs leadership teams. We continue to conduct pre-commercial preparations for the U.S., such as enhancing and/or establishing company processes and systems to support a potential commercial launch, refining our market research in lower-risk MDS, engaging in marketing and commercial access/reimbursement preparatory efforts, and hiring our sales force, which we expect to occur in the first and second quarters of 2024. We continue to evaluate our strategy for the potential launch and commercialization of imetelstat in Europe. Based on our internal estimates of pricing and addressable patient populations in 2031 and if regulatory authorities approve imetelstat for marketing in lower-risk MDS and relapsed/refractory MF, we believe the potential combined total addressable market opportunity in the U.S. and Europe for imetelstat is approximately $7.0 billion, of which lower-risk MDS represents approximately $3.5
billion and relapsed/refractory MF represents approximately $3.5 billion.
🐀 2 👺 1 😈 1
iclight iclight 2 hours ago
And for every one of those, there are 100 NWBOs that milk shareholders dry, make their money off inflated salaries, selling shares, and having no product, and then sitting in OTC pennystock purgatory for the rest of their existence.
🐀 3 👺 1 😈 1
iclight iclight 2 hours ago
To be fair one doesn't need a salesforce if they never have anything to sell but your point is certainly valid for legitimate companies.
🐀 2 👍️ 2 👺 1 😈 1
flyfishingcherokee flyfishingcherokee 2 hours ago
Flip, I'm not only still here, but buying more. My GTC order in for additional shares at 0.46 was filled this morning for about 1/3 of my order. The rest is still working. I can only control how I feel and what I choose to do. What other longs do is out of my control and I wish all longs the best .
🎯 1 🏆️ 1 👍️ 4 🖖 1
learningcurve2020 learningcurve2020 2 hours ago
You claimed retail shareholders have done nothing in all these years to strengthen yourselves as a group. You haven't even had a sit down with Bigger to maybe help your situation. He sure looks like he has plenty of time on his hands. LOL. Sorry folks but Social Media just isn't going to get you there. Wake up.
🐀 2 👍️ 1 👺 1 😈 1
iclight iclight 2 hours ago
You're welcome for my posts. And the reason many are here is because of the shilling of the senti's, flippers, ATLs and the many others who got buried by paper debt and don't even consider the opportunity cost of watching their paper holdings deteriorate for 10+years.

My "games" have nothing to do with the company's silence as they used to pump out weekly PRs. My "games" come from the blatant lying by the company, the withholding information, the lack of transparency, blaming everyone but themselves for the failure as a publicly traded company, and the inability for them to admit something as simple and devastating to the stock and company as the futility recommendation. I could rehash Bosch's many lies regarding pseudoprogression that were contradicted and corrected by Liau, but that scheister is still an officer of the company. So he will always lie if a microphone is in front of him.

They still don't file properly and ignore the basic rules of being a publicly traded company.

It's a scam. LP is laughing all the way to the bank. Advent sale coming soon.
🐀 3 👺 1 😈 1
H2R H2R 2 hours ago
Me too, been 'Long' over ten years, and definitely not selling shares now that we are this close. Once the submittal was official, there was no way I was going to sell a single share. Confidently hopeful.

Best of luck with your investments!
🎯 1 🏆️ 1 👍️ 2 🤞 1 🤡 1 🤣 1
learningcurve2020 learningcurve2020 2 hours ago
Just when you think Danish is waking up he always steps on a shovel.


>>The case is, that we are up against incredible powerful and financially empowered forces and that the company have made a decision, that not saying anything, will not be able to be used against them. That includes leaving retailers in the dark.
🐀 4 👍️ 1 👺 1 💩 1 😈 1
GermanCol GermanCol 2 hours ago
Thanks Margin Buu and good luck to you too. Yes, I am expecting a ROI from the shares I am holding. I think it is coming. Not sure if once we get MHRA approval or if we have to wait more time, but I hope we start to see a change soon.
👍️ 1
iclight iclight 2 hours ago
Advent has paying clients that it actually produces products for and makes money off of them.

LP poured NWBO money into Cognate. How'd that work out? Great for LP.
🐀 3 👍️ 2 👺 1 💥 1 💩 1
attilathehunt attilathehunt 2 hours ago
Agreed.

Once we approach the end of May, we could start to hear news "Any day now".

It is safe to assume with 1.7 pages of data, surely there will be questions that warrant a RFI...

I don't expect any news on approval until we are in June. Unfortunately, but realistic.
👍️0
learningcurve2020 learningcurve2020 3 hours ago
Sorry to see you go, Colonel. Just know that when I called you "Colonel Klink" it was out of tough love. I think you've smartened up now realizing the situation. But it's a shame you couldn't lead the way with other shareholders here to force management transparency and maybe even get a board seat rather than selling off.
🐀 2 👍️ 1 👺 1 😈 1
Single Stock Single Stock 3 hours ago
just looking at it ... jeez that's serious vol

In one week last year it went from 2.30 tp 6.93 and back to 2.23 ...

Good luck with that .
👍️0
GermanCol GermanCol 3 hours ago
Tired of the way communication is handled and saw another opportunity, but didn't have cash available. Anyway I kept part of my shares.
🎯 1 👍️ 1
GermanCol GermanCol 3 hours ago
Hi Single Stock. It is IBRX.
👍️0
GermanCol GermanCol 3 hours ago
Thanks The Danish Dude for your words and all your contribution on this board and Twitter. The same goes to you. I hope better days come for us soon.
👍️ 2
JRROBYN JRROBYN 3 hours ago
My God people, shorts again?

At what point do you blame management? BK? Ten cent SP?

I'd like the usual pumpers to let us know the threshold at which they blame management for this debacle. At which point will you admit you've been wrong and LP is using NWBO as an Advent ATM?
🐀 1 👍️ 2 👺 1 💩 2 💯 2 🖕 2
RobotDroid RobotDroid 3 hours ago
I feel and have been feeling your pain on this stock, thus my lack of faith in management to get anything done on time and even talk to the shareholders. You simply stated what many of us feel, and tomorrow never ever seems to come but keeps getting promised. The lack of transperity, communication, and accountability is the worse I have ever seen in a company I am invested in. That, sadly, is the real truth about nwbo and the clown show it has become due to silence.
🐀 1 👺 1 💩 1 🖕 1
GermanCol GermanCol 3 hours ago
Thanks Investor082. I agree with you. I hope this time is different and management can rebuild all the trust that we have lost.
👍️ 2

Your Recent History

Delayed Upgrade Clock